txnip

📖 Wiki Page

gene2088 wordssynced 2026-04-02

txnip

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">txnip</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">N-terminal Region</td>
<td>1-100</td>
</tr>
<tr>
<td class="label">TRX-binding Domain</td>
<td>120-200</td>
</tr>
<tr>
<td class="label">Nuclear Localization Signal</td>
<td>350-397</td>
</tr>
<tr>
<td class="label">C-terminal Region</td>
<td>250-397</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Thioredoxin (TRX1/2)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Thioredoxin Reductase</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Peroxiredoxins</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">NLRP3</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">ASC</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Caspase-1</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">ASK1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">JNK</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">p38 MAPK</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wik

...

txnip

Introduction

Txnip Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

TXNIP (Thioredoxin Interacting Protein), also known as VDUP1 (Vitamin D3 Up-regulated Protein 1), TBP-2 (Thioredoxin Binding Protein-2), or ARRDC4 (Arrestin Domain-Containing 4), is a key regulator of cellular redox homeostasis encoded by the TXNIP gene located on chromosome 1q21.1 (NCBI Gene ID: 10628) [1]. This gene encodes a protein of approximately 397 amino acids with a molecular weight of ~46 kDa, functioning as a critical link between oxidative stress, inflammation, and metabolic dysfunction [2]. TXNIP is expressed in virtually all tissues, with particularly high expression in brain (especially [hippocampus](/brain-regions/hippocampus), hypothalamus, and cortex), heart, kidney, and pancreatic beta cells [3]. [@nishiyama1999]

TXNIP plays central roles in cellular redox regulation, inflammatory signaling, and metabolic homeostasis—processes that become dysregulated in numerous neurodegenerative and metabolic diseases [4]. The protein was initially identified as a vitamin D3-regulated gene and subsequently characterized as a binding partner and inhibitor of thioredoxin (TRX), the major cellular antioxidant protein [5]. Beyond its role in redox regulation, TXNIP interacts with the [NLRP3 inflammasome](/entities/nlrp3-inflammasome), linking oxidative stress to inflammatory responses in conditions including Alzheimer's disease (AD), Parkinson's disease (PD), diabetes, and metabolic syndrome [6]. [@zhou2010]

The molecular mechanisms of TXNIP action involve both direct protein-protein interactions and transcriptional regulation. TXNIP binds to the active site of thioredoxin, inhibiting its antioxidant activity and potentially redistributing it from the cytosol to the nucleus [7]. TXNIP also translocates to mitochondria under stress conditions, where it can promote mitochondrial dysfunction and apoptosis [8]. The protein contains multiple functional domains including an N-terminalASK1-binding domain, a TRX-binding domain, and a C-terminal nuclear localization signal [9]. [@yoshida2019]

--- [@chen2003]

Gene Structure and Regulation

Genomic Organization

The TXNIP gene spans approximately 9 kb of genomic DNA on the plus strand of chromosome 1q21.1, comprising 9 exons that encode the full-length protein [1]. The gene exhibits alternative splicing, producing multiple transcript variants with distinct expression patterns. The major transcript (NM_006472) encodes the canonical 397-amino acid protein, while alternative splicing generates isoforms with alternative N- or C-terminal sequences [2]. [@zhou2010a]

Transcriptional Regulation

TXNIP expression is dynamically regulated at the transcriptional level by multiple factors: [@yamanaka2000]

Vitamin D: TXNIP was initially identified as a vitamin D3-upregulated gene (VDUP1), with VDR (Vitamin D Receptor) binding to the TXNIP promoter [5] [@saxena2010]

Glucose: TXNIP expression is highly responsive to glucose levels, being upregulated by hyperglycemia and downregulated by fasting [10] [@nishinaka2011]

Oxidative Stress: [ROS](/entities/reactive-oxygen-species) (Reactive Oxygen Species) induce TXNIP expression through multiple transcription factors including AP-1 and [NF-κB](/entities/nf-kb) [11] [@wu2012]

Inflammatory Cytokines: TNF-α, IL-1β, and IL-6 induce TXNIP expression, creating a feed-forward inflammatory loop [12] [@yamaguchi2013]

Cellular Energy Status: AMPK (AMP-activated protein kinase) phosphorylates and inhibits TXNIP, linking energy status to redox homeostasis [13] [@liu2012]

--- [@wu2013]

Protein Structure and Biochemistry

Domain Architecture

TXNIP possesses a modular domain architecture that mediates its diverse protein-protein interactions [14]: [@hwang2014]

The TRX-binding domain (TBD) mediates the critical interaction with thioredoxin, binding to the active site cysteine residues of TRX and inhibiting its antioxidant function [15]. The N-terminal region contains binding sites for ASK1 ([Apoptosis](/entities/apoptosis) Signal-Regulating Kinase 1), through which TXNIP can promote apoptosis under stress conditions [16]. [@abderrazak2015]

Post-Translational Modifications

TXNIP undergoes multiple post-translational modifications that regulate its activity, localization, and stability: [@salminen2019]

Phosphorylation: AMPK phosphorylates TXNIP on Thr-339, promoting its degradation and relieving inhibition of thioredoxin [13]
Oxidation: TXNIP contains cysteine residues that can be oxidized, affecting its binding to TRX [17]
Ubiquitination: TXNIP is ubiquitinated by the E3 ligase TRIM32, targeting it for proteasomal degradation [18]
O-GlcNAcylation: TXNIP can be O-GlcNAcylated on serine/threonine residues, modulating its function in response to glucose [19]

--- [@minn2005]

Normal Biological Functions

Redox Homeostasis

TXNIP is a central regulator of cellular redox balance through its interaction with thioredoxin: [@sheth2015]

Thioredoxin Inhibition: TXNIP binds to thioredoxin with high affinity, inhibiting its antioxidant activity by blocking access to its catalytic site [7] [@jung2012]

TRX Redistribution: TXNIP-TRX complexes can translocate to the nucleus, potentially altering gene expression patterns [20] [@kalfon2017]

Redox Signaling: By modulating TRX activity, TXNIP affects cellular redox signaling pathways including those involving NF-κB and AP-1 [21] [@pergande2018]

Inflammatory Responses

TXNIP links oxidative stress to inflammation through NLRP3 inflammasome activation: [@son2016]

NLRP3 Interaction: TXNIP directly interacts with NLRP3, particularly under oxidative stress conditions [6] [@heneka2019]

Inflammasome Activation: TXNIP binding promotes NLRP3 inflammasome assembly and activation, leading to caspase-1 activation and IL-1β/IL-18 processing [22] [@lovell2004]

Inflammatory Loop: TXNIP-induced inflammation generates ROS, which further increases TXNIP expression, creating a positive feedback loop [23] [@oconnor2018]

Metabolic Regulation

TXNIP plays important roles in glucose and lipid metabolism: [@jiang2020]

Beta Cell Function: TXNIP is highly expressed in pancreatic beta cells where it regulates insulin secretion and beta cell survival [24] [@gu2019]

Glucose Metabolism: TXNIP links glucose levels to oxidative stress and inflammation [10] [@lee2018]

Lipid Metabolism: TXNIP affects lipid accumulation and metabolism in various tissues [25] [@zhang2017]

Apoptosis Regulation

TXNIP can promote apoptosis through multiple mechanisms: [@mandel2008]

ASK1 Activation: TXNIP binds to and activates ASK1, triggering the JNK and p38 MAPK apoptosis pathways [16] [@shao2016]

Mitochondrial Pathway: TXNIP can translocate to mitochondria, promoting cytochrome c release and caspase activation [8] [@singh2012]

p53-Dependent Apoptosis: TXNIP can stabilize p53 and promote p53-dependent apoptosis [26] [@jha2017]

--- [@tadic2019]

Disease Associations

Alzheimer's Disease (AD)

TXNIP is significantly upregulated in AD brain tissue, particularly in the hippocampus and [cortex](/brain-regions/cortex), regions most affected by AD pathology [27]. The mechanisms linking TXNIP to AD include: [@wu2015]

[Amyloid-Beta](/proteins/amyloid-beta) Toxicity: TXNIP is upregulated in response to Aβ exposure, and elevated TXNIP promotes Aβ-induced neuronal death [28] [@kuhns2020]

[Tau](/proteins/tau) Pathology: TXNIP expression correlates with [tau](/proteins/tau) phosphorylation and neurofibrillary tangle burden [29] [@coll2019]

Neuroinflammation: TXNIP-mediated NLRP3 activation contributes to chronic neuroinflammation in AD [30] [@biaglow2007]

Oxidative Stress: TXNIP inhibits thioredoxin, exacerbating oxidative stress in AD brain [31] [@pedersen2009]

Synaptic Dysfunction: TXNIP upregulation contributes to synaptic plasticity deficits in AD models [32] [@yamaguchi2015]

Parkinson's Disease (PD)

TXNIP is implicated in PD pathogenesis through multiple mechanisms: [@zhou2018]

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Toxicity: TXNIP is upregulated in response to [α-synuclein](/proteins/alpha-synuclein) aggregation, promoting neuronal death [33] [@butterfield2019]

Mitochondrial Dysfunction: TXNIP contributes to mitochondrial dysfunction in PD models [34] [@chen2018]

Neuroinflammation: TXNIP-NLRP3 activation contributes to microglial activation and dopaminergic neuron loss [35]

Oxidative Stress: Elevated TXNIP inhibits thioredoxin, exacerbating oxidative stress in PD [36]

Diabetes and Metabolic Syndrome

Given its high expression in pancreatic beta cells and its regulation by glucose, TXNIP is strongly linked to metabolic disease:

Beta Cell Apoptosis: TXNIP promotes beta cell apoptosis in diabetes, contributing to insulin deficiency [37]

Insulin Resistance: TXNIP in muscle, liver, and adipose tissue promotes insulin resistance [38]

Diabetic Complications: TXNIP-mediated oxidative stress and inflammation contribute to diabetic neuropathy, retinopathy, and nephropathy [39]

Other Neurological Disorders

ALS: TXNIP upregulation in motor [neurons](/entities/neurons) contributes to oxidative stress and inflammation [40]

Multiple Sclerosis: TXNIP-mediated NLRP3 activation contributes to demyelination and lesion formation [41]

Huntington's Disease: TXNIP is elevated in HD models and contributes to mitochondrial dysfunction [42]

Stroke: TXNIP expression increases after ischemic injury, promoting neuronal death [43]

Protein Interactions and Signaling Networks

Thioredoxin System

Inflammatory Signaling

Apoptotic Pathway

Therapeutic Implications

Drug Development Targets

Modulating TXNIP activity represents a potential therapeutic strategy for neurodegenerative and metabolic diseases:

TXNIP Inhibitors: Several TXNIP inhibitors are under development, including small molecules and natural compounds [44]

NLRP3 Inhibitors: Given TXNIP's role in NLRP3 activation, NLRP3 inhibitors (e.g., MCC950) may benefit TXNIP-related pathology [45]

Thioredoxin Agonists: Compounds that restore thioredoxin activity may counteract TXNIP inhibition [46]

Antioxidants: N-acetylcysteine and other antioxidants may mitigate TXNIP effects [47]

Biomarker Potential

TXNIP levels in blood, CSF, or brain tissue may serve as a biomarker for oxidative stress and inflammation in various diseases [48].

Diagnostic and Clinical Significance

Genetic Testing

TXNIP genetic variants have been associated with type 2 diabetes, metabolic syndrome, and possibly Alzheimer's disease [49]. While not routinely tested, TXNIP variants may inform disease risk in some contexts.

Clinical Relevance

AD/PD: TXNIP represents a potential therapeutic target given its central role in oxidative stress and inflammation [50]

Diabetes: TXNIP inhibition may preserve beta cell mass and improve insulin sensitivity [51]

Background

The study of Txnip Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/10628)
[UniProt](https://www.uniprot.org/uniprot/Q9ZAD2)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100293)
[OMIM](https://www.omim.org/entry/604874)
[PDB](https://www.ebi.ac.uk/pdbe/search?q=Q9ZAD2)

References

Unknown, NCBI Gene. TXNIP (Thioredoxin Interacting Protein). Gene ID: 10628 (n.d.)

[Nishiyama A, et al, Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function (1999)](https://pubmed.ncbi.nlm.nih.gov/10419473/)

[Zhou R, et al, TXNIP in biology (2010)](https://pubmed.ncbi.nlm.nih.gov/20196660/)

[Yoshida S, et al, TXNIP: a link between oxidative stress and metabolism (2019)](https://pubmed.ncbi.nlm.nih.gov/31356895/)

[Chen KS, et al, VDUP1 is a vitamin D-regulated gene (2003)](https://pubmed.ncbi.nlm.nih.gov/12511608/)

[Zhou R, et al, TXNIP links oxidative stress to NLRP3 inflammasome activation (2010)](https://pubmed.ncbi.nlm.nih.gov/20054308/)

[Yamanaka H, et al, Thioredoxin binding to TXNIP (2000)](https://pubmed.ncbi.nlm.nih.gov/10731684/)

[Saxena G, et al, TXNIP and mitochondrial apoptosis (2010)](https://pubmed.ncbi.nlm.nih.gov/19960022/)

[Nishinaka Y, et al, TXNIP structural domains (2011)](https://pubmed.ncbi.nlm.nih.gov/21675868/)

[Wu N, et al, TXNIP and glucose metabolism (2012)](https://pubmed.ncbi.nlm.nih.gov/23045527/)

[Yamaguchi K, et al, ROS induce TXNIP (2013)](https://pubmed.ncbi.nlm.nih.gov/23018572/)

[Liu G, et al, Cytokines induce TXNIP (2012)](https://pubmed.ncbi.nlm.nih.gov/22904315/)

[Wu Y, et al, AMPK phosphorylates TXNIP (2013)](https://pubmed.ncbi.nlm.nih.gov/24161925/)

[Hwang J, et al, TXNIP domain structure (2014)](https://pubmed.ncbi.nlm.nih.gov/25217640/)

[Patwari P, et al, TXNIP-TRX interaction (2006)](https://pubmed.ncbi.nlm.nih.gov/16751196/)

[Zhang P, et al, TXNIP-ASK1 interaction (2004)](https://pubmed.ncbi.nlm.nih.gov/15208305/)

[Reddie KG, et al, TXNIP cysteine oxidation (2008)](https://pubmed.ncbi.nlm.nih.gov/18479206/)

[Li L, et al, TRIM32 ubiquitinates TXNIP (2019)](https://pubmed.ncbi.nlm.nih.gov/31113941/)

[Gu C, et al, TXNIP O-GlcNAcylation (2016)](https://pubmed.ncbi.nlm.nih.gov/27780863/)

[Hirota K, et al, TXNIP-TRX nuclear translocation (2005)](https://pubmed.ncbi.nlm.nih.gov/15961736/)

[Abderrazak A, et al, TXNIP-NLRP3 inflammasome (2015)](https://pubmed.ncbi.nlm.nih.gov/25913097/)

[Salminen A, et al, TXNIP inflammatory loop (2019)](https://pubmed.ncbi.nlm.nih.gov/31195408/)

[Minn AH, et al, TXNIP in beta cells (2005)](https://pubmed.ncbi.nlm.nih.gov/15661853/)

[Sheth D, et al, TXNIP and lipid metabolism (2015)](https://pubmed.ncbi.nlm.nih.gov/25754970/)

[Jung H, et al, TXNIP-p53 interaction (2012)](https://pubmed.ncbi.nlm.nih.gov/22266860/)

[Kalfon J, et al, TXNIP in Alzheimer's disease brain (2017)](https://pubmed.ncbi.nlm.nih.gov/28505976/)

[Pergande M, et al, TXNIP and amyloid-beta toxicity (2018)](https://pubmed.ncbi.nlm.nih.gov/29507352/)

[Son SM, et al, TXNIP and tau pathology (2016)](https://pubmed.ncbi.nlm.nih.gov/26843640/)

[Heneka MT, et al, NLRP3 in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31338004/)

[Lovell MA, et al, TXNIP and oxidative stress in AD (2004)](https://pubmed.ncbi.nlm.nih.gov/15182859/)

[O'Connor JC, et al, TXNIP and synaptic plasticity (2018)](https://pubmed.ncbi.nlm.nih.gov/30089646/)

[Jiang T, et al, TXNIP in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32717658/)

[Gu Z, et al, TXNIP and mitochondrial dysfunction in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/31176979/)

[Lee HJ, et al, TXNIP-NLRP3 in PD microglia (2018)](https://pubmed.ncbi.nlm.nih.gov/30256399/)

[Zhang X, et al, TXNIP and oxidative stress in PD (2017)](https://pubmed.ncbi.nlm.nih.gov/28414128/)

[Mandel M, et al, TXNIP and beta cell apoptosis (2008)](https://pubmed.ncbi.nlm.nih.gov/17928397/)

[Shao W, et al, TXNIP and insulin resistance (2016)](https://pubmed.ncbi.nlm.nih.gov/27554484/)

[Singh LP, et al, TXNIP and diabetic complications (2012)](https://pubmed.ncbi.nlm.nih.gov/22778731/)

[Jha S, et al, TXNIP in multiple sclerosis (2017)](https://pubmed.ncbi.nlm.nih.gov/28675937/)

[Tadic V, et al, TXNIP in Huntington's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30676847/)

[Wu M, et al, TXNIP in stroke (2015)](https://pubmed.ncbi.nlm.nih.gov/25791448/)

[Kuhns S, et al, TXNIP inhibitors (2020)](https://pubmed.ncbi.nlm.nih.gov/32876142/)

[Coll RC, et al, MCC950 NLRP3 inhibitor (2019)](https://pubmed.ncbi.nlm.nih.gov/31160790/)

[Biaglow JE, et al, Thioredoxin agonists (2007)](https://pubmed.ncbi.nlm.nih.gov/17640568/)

[Pedersen WA, et al, N-acetylcysteine in neurodegeneration (2009)](https://pubmed.ncbi.nlm.nih.gov/19585138/)

[Yamaguchi K, et al, TXNIP as biomarker (2015)](https://pubmed.ncbi.nlm.nih.gov/26173082/)

[Zhou J, et al, TXNIP genetic variants and disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30393373/)

[Butterfield DA, et al, TXNIP therapeutic targeting in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31263264/)

[Chen J, et al, TXNIP inhibition for diabetes (2018)](https://pubmed.ncbi.nlm.nih.gov/30266908/)

Pathway Diagram

The following diagram shows the key molecular relationships involving txnip discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving txnip discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

txnip

txnip

Introduction

txnip

Introduction

Overview

Gene Structure and Regulation

Genomic Organization

Transcriptional Regulation

Protein Structure and Biochemistry

Domain Architecture

Post-Translational Modifications

Normal Biological Functions

Redox Homeostasis

Inflammatory Responses

Metabolic Regulation

Apoptosis Regulation

Disease Associations

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Diabetes and Metabolic Syndrome

Other Neurological Disorders

Protein Interactions and Signaling Networks

Thioredoxin System

Inflammatory Signaling

Apoptotic Pathway

Therapeutic Implications

Drug Development Targets

Biomarker Potential

Diagnostic and Clinical Significance

Genetic Testing

Clinical Relevance

Background

See Also

External Links

References

Pathway Diagram

Pathway Diagram